Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Jharna, Datta"'
Autor:
Jasmine M. Manouchehri, Jharna Datta, Lynn M. Marcho, Jesse J. Reardon, Daniel Stover, Robert Wesolowski, Uma Borate, Ting-Yuan David Cheng, Patrick M. Schnell, Bhuvaneswari Ramaswamy, Gina M. Sizemore, Mark P. Rubinstein, Mathew A. Cherian
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-14 (2024)
Abstract Background Breast cancer, one of the most common forms of cancer, is associated with the highest cancer-related mortality among women worldwide. In comparison to other types of breast cancer, patients diagnosed with the triple-negative breas
Externí odkaz:
https://doaj.org/article/43956b4eb5884e51bd8d76ab76b808d6
Autor:
Jasmine M. Manouchehri, Jharna Datta, Natalie Willingham, Robert Wesolowski, Daniel Stover, Ramesh K. Ganju, William E. Carson, Bhuvaneswari Ramaswamy, Mathew A. Cherian
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionBreast cancer affects two million patients worldwide every year and is the most common cause of cancer-related death among women. The triple-negative breast cancer (TNBC) sub-type is associated with an especially poor prognosis because cu
Externí odkaz:
https://doaj.org/article/694476ef3887421ab30a77418e5121cb
Autor:
Jharna Datta, Natalie Willingham, Jasmine M. Manouchehri, Patrick Schnell, Mirisha Sheth, Joel J. David, Mahmoud Kassem, Tyler A. Wilson, Hanna S. Radomska, Christopher C. Coss, Chad E. Bennett, Ramesh K. Ganju, Sagar D. Sardesai, Maryam Lustberg, Bhuvaneswari Ramaswamy, Daniel G. Stover, Mathew A. Cherian
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAmong women, breast cancer is the leading cause of cancer-related death worldwide. Estrogen receptor α-positive (ERα+) breast cancer accounts for 70% of all breast cancer subtypes. Although ERα+ breast cancer initially responds to estrog
Externí odkaz:
https://doaj.org/article/432a0e095a4c45e2800716a4915a5e12
Autor:
Rahul Mal, Alexa Magner, Joel David, Jharna Datta, Meghna Vallabhaneni, Mahmoud Kassem, Jasmine Manouchehri, Natalie Willingham, Daniel Stover, Jeffery Vandeusen, Sagar Sardesai, Nicole Williams, Robert Wesolowski, Maryam Lustberg, Ramesh K. Ganju, Bhuvaneswari Ramaswamy, Mathew A. Cherian
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) belong to a superfamily of nuclear receptors called steroid hormone receptors, which, upon binding ligand, dimerize and translocate to the nucleus where they activate or repress the tra
Externí odkaz:
https://doaj.org/article/e10d89465998455496bb1a64694d5fae
Autor:
Sameek Roychowdhury, Julie W. Reeser, John Hays, Darshna Bhatt, Michele R. Wing, Eric Samorodnitsky, Elijah P. Gardner, Lianbo Yu, Jharna Miya, Cristina Ocrainiciuc, Hannah Parks, Senthilkumar Damodaran, Jharna Datta
Supplemental Table 1. Expression of FGFR1 and FGFR3 in different cell lines; Supplemental Table 2. Normalized Reverse Phase Protein Array Results for DMS114; Supplemental Table 3. Normalized Reverse Phase Protein Array Results for RT112; Supplemental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe23a1ab4c50d46d2da9d0726f4769c
https://doi.org/10.1158/1535-7163.22507821
https://doi.org/10.1158/1535-7163.22507821
Autor:
Sameek Roychowdhury, Julie W. Reeser, John Hays, Darshna Bhatt, Michele R. Wing, Eric Samorodnitsky, Elijah P. Gardner, Lianbo Yu, Jharna Miya, Cristina Ocrainiciuc, Hannah Parks, Senthilkumar Damodaran, Jharna Datta
Chemical structures of inhibitors of FGFR (BGJ398) and Akt (GSK2141795).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03d565f0bdd16ecc17a65dbf6c214f01
https://doi.org/10.1158/1535-7163.22507842
https://doi.org/10.1158/1535-7163.22507842
Autor:
Sameek Roychowdhury, Julie W. Reeser, John Hays, Darshna Bhatt, Michele R. Wing, Eric Samorodnitsky, Elijah P. Gardner, Lianbo Yu, Jharna Miya, Cristina Ocrainiciuc, Hannah Parks, Senthilkumar Damodaran, Jharna Datta
FGFR 1 and FGFR3 expression in DMS114 and RT112 cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297c13c73ff81ade85ab5a0d4165770e
https://doi.org/10.1158/1535-7163.22507845
https://doi.org/10.1158/1535-7163.22507845
Autor:
Quintin Pan, Anna K. Mapp, Theodoros N. Teknos, Xiujie Xie, James C. Lang, Jharna Datta, Longzhu Piao, Manchao Zhang
Supplemental Figure 1. Restoration of miR-124 in CAL27 enhances the anti-tumor efficacy of afatinib.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e7d60842ce6b18268bbff1f6420547
https://doi.org/10.1158/1535-7163.22502308
https://doi.org/10.1158/1535-7163.22502308
Autor:
Sameek Roychowdhury, Julie W. Reeser, John Hays, Darshna Bhatt, Michele R. Wing, Eric Samorodnitsky, Elijah P. Gardner, Lianbo Yu, Jharna Miya, Cristina Ocrainiciuc, Hannah Parks, Senthilkumar Damodaran, Jharna Datta
Activation of FGFR signaling through mutations, amplifications, or fusions involving FGFR1, 2, 3, or 4 is seen in multiple tumors, including lung, bladder, and cholangiocarcinoma. Currently, several clinical trials are evaluating the role of novel FG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e21686828eb56109db6f049a67750f
https://doi.org/10.1158/1535-7163.c.6538800
https://doi.org/10.1158/1535-7163.c.6538800
Autor:
Quintin Pan, Anna K. Mapp, Theodoros N. Teknos, Xiujie Xie, James C. Lang, Jharna Datta, Longzhu Piao, Manchao Zhang
Supplemental Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0ff798b0b609366ce7eca973c5f8824
https://doi.org/10.1158/1535-7163.22502311.v1
https://doi.org/10.1158/1535-7163.22502311.v1